IPA has drawn the attention of USTR to the rapid progress made by India on a number of fronts, which were cited by USTR while placing India on the Priority Watch List in 2018
Drug major Dr Reddy's Laboratories had received an unfavourable ruling in a US court regarding a patent infringement case over anti-nausea injection Aloxi.
Indian pharmaceutical companies have an opportunity to capitalise on the patent cliff and gain a greater share of the growing generics market.
Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.